European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week
AI Sentiment
Positive
7/10
as of 12-04-2025 9:30am EST
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
| Founded: | 1979 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 75.5M | IPO Year: | 1997 |
| Target Price: | $8.50 | AVG Volume (30 days): | 41.0K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $3.05 | Next Earning Date: | 11-06-2025 |
| Revenue: | $74,853,925 | Revenue Growth: | 0.61% |
| Revenue Growth (this year): | -3.8% | Revenue Growth (next year): | 2.67% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
EDAP Breaking Stock News: Dive into EDAP Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
See how EDAP stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "EDAP EDAP TMS S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.